In the present study, we firstly tested the L1CAM expression in the metastatic brain lesion in patients with brain metastases from lung cancer who were treated with neurosurgical tumor resection and the L1CAM expression in peripheral blood in the one treated with non-surgical antitumor management. The gene discussed is L1CAM; the disease is neoplasm.